Oneview Healthcare (ONE) Q1 2026 TU earnings summary

Executive summary

• Cash balance at 31 March 2026 was €10.3 million, up from €4.6 million at 31 December 2025, driven by a successful capital raise.

• Net cash outflow for the quarter was €1.1 million, lower than the €1.6 million outflow in Q1 2025, reflecting reduced operating costs post-restructuring.

• Ongoing expansion of customer base and product development, including progress on the AI-enabled Care Assistant, Ovie.

• Strong lead generation and engagement at major industry conferences, supporting sales pipeline momentum.

Financial highlights

• Customer receipts for Q1 2026 were €3.3 million, down from €4.2 million in Q1 2025 due to timing of large receipts in the prior year.

• Net cash used in operating activities was €1.27 million for the quarter.

• Payments to related parties totaled €434,475 for directors' fees and salaries.

• Cash and cash equivalents increased to €10.3 million at quarter end, up from €4.6 million at the start of the quarter.

Outlook and guidance

• Management expects continued momentum in sales and deployment activity, supported by a strengthened balance sheet.

• Growing demand for digitally supported bedside experiences and ongoing virtualisation of care are expected to drive further adoption.